Active Immunization with a Detoxified<i>Escherichia coli</i>J5 Lipopolysaccharide Group B Meningococcal Outer Membrane Protein Complex Vaccine Protects Animals from Experimental SepsisAlan S. Cross, Apurba K. Bhattacharjee, Nicolas A. Parejo et al.|The Journal of Infectious Diseases|2001Cited by 43
Recombinant Human Interleukin‐11 in Experimental<i>Pseudomonas aeruginosa</i>Sepsis in Immunocompromised AnimalsSteven M. Opal, Apurba K. Bhattacharjee, Jhung W. Jhung et al.|The Journal of Infectious Diseases|1998Cited by 36
Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsisAlan S. Cross, Apurba K. Bhattacharjee, Steven M. Opal et al.|Vaccine|2003Cited by 32
Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjectsAlan S. Cross, Apurba K. Bhattacharjee, Steven M. Opal et al.|Vaccine|2003Cited by 31
Immunotherapy of sepsis: flawed concept or faulty implementation?Alan S. Cross, Stanley J. Cryz, Steven M. Opal et al.|Vaccine|1999Cited by 31